Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC
The objectives of this study were: (1) to assess the safety, tolerability, and pharmacokinetics of ascending doses of Δ9-tetrahydrocannabinol-hemisuccinate (THC-HS) after rectal administration as suppositories in male volunteers; and (2) to compare the pharmacokinetics of oral administrat...
Saved in:
| Main Authors: | Mahmoud A. ElSohly, Waseem Gul, Larry A. Walker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2018-06-01
|
| Series: | Medical Cannabis and Cannabinoids |
| Online Access: | https://karger.com/article/doi/10.1159/000489037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice
by: Sarah A. Brendle, et al.
Published: (2025-06-01) -
Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
by: Pascale Meyer, et al.
Published: (2018-06-01) -
The Pharmacokinetics of Δ<sup>9</sup>-Tetrahydrocannabinol in Sheep
by: Sarah A. Stevens, et al.
Published: (2024-11-01) -
Pharmacokinetics and Side Effects of Δ9-Tetrahydrocannabinol and Cannabidiol in Patients with Different Stages of CKD
by: Marie Bach Sønderskov, et al.
Published: (2025-03-01) -
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
by: Janet Weber, et al.
Published: (2009-01-01)